Study Examines Availability, Accessibility Of Long-Acting Reversible Contraceptives In 3 African Countries

PSI’s “Impact”: Shifting Into High Gear on FP2020 Goals — The Critical Role of Implants and Other LARCs
Katherine Thanel, lead behavioral health planner at J&M Global Solutions, discusses results from a market survey that examined “market composition, trends in product availability, and pricing” of family planning methods, including long-acting reversible contraceptives (LARCs), in three study countries: Ethiopia, Nigeria, and the Democratic Republic of Congo. Thanel concludes, “As we approach 2020, it is imperative that investment in LARCs, especially implants, is prioritized” (4/10).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.